Business Context and Reporting Period
This Form 8-K is filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on July 6, 2021. The report addresses the resolution of a Nasdaq listing compliance issue regarding independent director and audit committee requirements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on corporate governance and listing status rather than financial performance.
Material Changes
- Listing Status Resolution: Nasdaq determined the Company is now in compliance with Listing Rules 5605(b)(1) and 5605(c)(2) regarding independent directors and the audit committee.
- Board Appointments: Compliance was achieved following the appointments of Pamela G. Marrone and Francis Kneuttel II to the Board of Directors and audit committee.
- Case Closure: The matter regarding the potential delisting or failure to satisfy continued listing rules is now closed.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on future operations. The primary risk addressed was the potential delisting from The Nasdaq Capital Market, which has been mitigated by the Company's successful compliance with the required governance standards.
Investor Verification Checklist
- Verify the Company name is 180 Life Sciences Corp. (Ticker: ATNF), not Forum Markets Inc.
- Confirm the effective date of the new board appointments (Pamela G. Marrone and Francis Kneuttel II) referenced in prior 8-K filings from June 2021.
- Check subsequent filings for any new governance or financial updates, as this report contains no financial data.